244161-09-9 Usage
Uses
Used in Medicinal Chemistry Research:
(S)-2-(3,5-Dioxopiperazin-1-yl)propanoic acid is utilized as a research tool for investigating the structure-activity relationships of compounds related to GABA and piperazine. Its unique structure allows scientists to study the effects of modifications on biological activity, which is crucial for the development of new drugs with improved efficacy and selectivity.
Used in Drug Development:
In the pharmaceutical industry, (S)-2-(3,5-Dioxopiperazin-1-yl)propanoic acid is employed as a lead compound in the development of new medications. Its potential biological activity and relationship to GABA suggest that it may have applications in the treatment of neurological disorders or as a modulator of neurotransmission.
Used in Neurotransmission Modulation:
Given its structural similarity to GABA, a key inhibitory neurotransmitter in the central nervous system, (S)-2-(3,5-Dioxopiperazin-1-yl)propanoic acid may be used as a modulator of neurotransmission. Its application could be particularly relevant in conditions where GABAergic signaling is implicated, such as epilepsy, anxiety disorders, or certain mood disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 244161-09-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,4,1,6 and 1 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 244161-09:
(8*2)+(7*4)+(6*4)+(5*1)+(4*6)+(3*1)+(2*0)+(1*9)=109
109 % 10 = 9
So 244161-09-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H10N2O4/c1-4(7(12)13)9-2-5(10)8-6(11)3-9/h4H,2-3H2,1H3,(H,12,13)(H,8,10,11)/t4-/m0/s1
244161-09-9Relevant academic research and scientific papers
Prevention and treatment of cardiac conditions
-
Page/Page column 22, (2008/12/08)
The present invention provides a method of treating conditions associated with iron and calcium overload comprising administering an effective amount of dexrazoxane or a non-dexrazoxane compound of formula (IA), (IB), or (IC) or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof.
